The Daily Papule

JIDLaboratory research

Defensins mediate skin inflammation and itch in psoriasis.

Balaji SK, Zheng Q, Yu H, Truong J, Benjamin Fernando LG, Liu Y, Shin C, Luo W, Dong X, Dong X

Journal of Investigative DermatologyIn the feed 9 Sep 2026, published online 9 Sep 2026, issue 2026 Sep 09, added to PubMed 9 Sep 2026

Topics: PsoriasisItch & prurigo

Abstract

Psoriasis is an inflammatory skin condition that features marked upregulation of keratinocyte-derived antimicrobial peptides, particularly β-defensins. Yet, the functions of these peptides in skin inflammation remain unclear. In this study, we used a defensin cluster-knockout mouse to evaluate the potential roles of defensins as neuroimmune modulators in psoriasis. Deletion of the defensin gene cluster (Def conditional knockout) in keratinocytes significantly attenuated imiquimod-induced psoriatic inflammation, with reduced hyperkeratosis, erythema, scaling, and expression of inflammatory cytokines and chemokines. In addition, the Def conditional-knockout mice exhibited reduced neutrophil and IL-17+ TCRγδ T-cell infiltration in the psoriatic skin, indicating a critical role of defensins in amplifying T helper 17 immunity. Behavioral analysis further revealed that the loss of defensins reduced psoriatic itch, and we showed that human β-defensin 2 directly activated small-diameter Mrgpra3 neurons to elicit robust scratching. Overall, our study revealed that β-defensins play an important role in mediating inflammation and itch associated with psoriasis by activating neutrophils, type 17 immune response, and pruriceptive sensory neurons, suggesting defensin signaling as a potential therapeutic target in psoriasis.

Abstract from PubMed

PMID 42716217 · DOI 10.1016/j.jid.2026.08.014